Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial

The efficacy and safety of the RTS,S/AS01 candidate malaria vaccine during 18 months of follow-up have been published previously. Herein, we report the final results from the same trial, including the efficacy of a booster dose.

Read More
Publication Date: 
04/07/2015
Lancet
386
9988
31-45
Tags:
Malaria, Vector Borne Diseases, Medical Research, Child Health, Africa, Drugs, Vector Control